Related Experiment Video
Updated: Feb 26, 2026
11:07
Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding
Published on: September 21, 2011
16.9K
Steroid Bioconversions.
1G.K. Skryabin Institute of Biochemistry & Physiology of Microorganisms, Russian Academy of Sciences, Prospekt Nauki, 5, Puschino, Russia, 142290. maryvdon@gmail.com.
Methods in Molecular Biology (Clifton, N.J.)
|July 16, 2017
Summary
Microbial bioconversions are key for producing valuable steroidal drugs. Genetic engineering and molecular microbiology create improved microbial biocatalysts for efficient steroid transformations.
Area of Science:
- Biotechnology
- Microbiology
- Organic Chemistry
Background:
- Microbial steroid modifications are vital for pharmaceutical production.
- Microorganisms perform diverse reactions like side-chain degradation and oxyfunctionalization.
- Established industrial bioprocesses utilize steroid-transforming microbial strains.
Purpose of the Study:
- To review the current state and future prospects of microbial bioconversions in steroid modification.
- To highlight the role of molecular microbiology in developing novel biocatalysts.
- To emphasize the importance of strain selection and engineering for improved bioprocesses.
Main Methods:
- Utilizing wild-type and engineered microbial strains for steroid transformations.
- Applying genetic and metabolic engineering techniques.
- Leveraging enzymatic and whole-cell biocatalysis approaches.
- Employing molecular microbiology methods for biocatalyst development.
Main Results:
- Microbial bioconversions offer effective routes to high-value steroidal drugs and precursors.
- Engineered strains enhance selectivity and efficiency in steroid modification.
- Biocatalytic methods provide a platform for generating known and novel bioactive metabolites.
Conclusions:
- Microbial bioconversions are a powerful tool in pharmaceutical manufacturing.
- Advancements in genetic engineering and molecular microbiology are crucial for developing superior biocatalysts.
- Continued research will drive innovation in microbial steroid transformations for new drug discovery.
Related Concept Videos
01:16Drug Biotransformation: Overview
4.0K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
4.0K
01:28Drug Biotransformation: Overview
4.0K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
4.0K
01:25Bioactivation and Tissue Toxicity
65
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
65
01:19Factors Affecting Drug Biotransformation: Biological
743
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
743
01:16Bioequivalence: Overview
2.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
2.1K
01:30Prodrugs
4.5K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
4.5K